'Real-life' reduction in cholesterol with statins, 1993 to 2002.

"Competing interests: M.J. Murphy has within the last 3 years received honorariums for lectures and advisory boards from Abbott, AstraZeneca, Fournier and Roche Pharmaceuticals. L. Wei declares no competing interests. A.D. Watson has within the last 3 years received honorariums from Novartis and Recordati. T.M. MacDonald has within the last 3 years received honorariums for lectures and advisory boards from Kaiser Permanente, Novartis, Pfizer, Recordati, Takeda and Speedel."

"This work was supported by a grant from the Chief Scientist Office of the Scottish Executive (CZG/2/148), with pump-priming funding from EastRen (Project no. 106-04). The sponsors of the study had no role in study design, data analysis, data interpretation or writing of the report. All authors had full access to all of the data in the study."